REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Cancerologia De Boyaca Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Centro De Cancerologia De Boyaca Sas Profile Updated: March 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Centro De Cancerologia De Boyaca Sas is an enterprise in Colombia, with the main office in Tunja. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on October 15, 1997. From the latest financial highlights, Centro De Cancerologia De Boyaca Sas reported a net sales revenue increase of 61.66% in 2024. Its’ total assets recorded a growth of 59.24%. The net profit margin of Centro De Cancerologia De Boyaca Sas increased by 3.16% in 2024.

Headquarters
Avenida Universitaria 46 - 71
Tunja; Boyaca;

Contact Details: Purchase the Centro De Cancerologia De Boyaca Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Cancerologia De Boyaca Sas report to view the information.
Incorporation Date:
October 15, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Created with Highstock 1.3.7Chart context menu2021Y2022Y2023Y2024Y
Net sales revenue
Net Profit (Loss) for the Period
Net Profit Margin
Financial values in the chart are available after Centro De Cancerologia De Boyaca Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
61.66%
Total operating revenue
61.66%
Operating profit (EBIT)
74.61%
EBITDA
79.47%
Net Profit (Loss) for the Period
90.77%
Total assets
59.24%
Total equity
85.6%
Operating Profit Margin (ROS)
2.45%
Net Profit Margin
3.16%
Return on Equity (ROE)
1.25%
Debt to Equity Ratio
-57.57%
Quick Ratio
0.18%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?